Klingenstein Fields & Co’s Quest Diagnostics DGX Stock Holding History

Klingenstein Fields & Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,000	Closed	-$719K	–	196
2025 Q2	$719K	Hold	4,000	–	–	0.03%	108
2025 Q1	$677K	Hold	4,000	–	–	0.03%	110
2024 Q4	$603K	Hold	4,000	–	–	0.02%	114
2024 Q3	$621K	Hold	4,000	–	–	0.02%	112
2024 Q2	$548K	Hold	4,000	–	–	0.02%	114
2024 Q1	$532K	Hold	4,000	–	–	0.02%	117
2023 Q4	$552K	Hold	4,000	–	–	0.02%	113
2023 Q3	$487K	Hold	4,000	–	–	0.02%	112
2023 Q2	$562K	Hold	4,000	–	–	0.03%	107
2023 Q1	$566K	Hold	4,000	–	–	0.03%	105
2022 Q4	$626K	Hold	4,000	–	–	0.03%	109
2022 Q3	$491K	Hold	4,000	–	–	0.03%	115
2022 Q2	$532K	Hold	4,000	–	–	0.03%	118
2022 Q1	$547K	Hold	4,000	–	–	0.02%	127
2021 Q4	$692K	Hold	4,000	–	–	0.03%	117
2021 Q3	$581K	Hold	4,000	–	–	0.02%	130
2021 Q2	$528K	Hold	4,000	–	–	0.02%	133
2021 Q1	$513K	Hold	4,000	–	–	0.02%	130
2020 Q4	$477K	Hold	4,000	–	–	0.02%	135
2020 Q3	$458K	Hold	4,000	–	–	0.02%	133
2020 Q2	$456K	Hold	4,000	–	–	0.02%	130
2020 Q1	$321K	Sell	4,000 -485	-11%	-$50.2K	0.02%	141
2019 Q4	$479K	Hold	4,485	–	–	0.02%	134
2019 Q3	$480K	Hold	4,485	–	–	0.03%	137
2019 Q2	$457K	Hold	4,485	–	–	0.02%	141
2019 Q1	$403K	Hold	4,485	–	–	0.02%	149
2018 Q4	$373K	Hold	4,485	–	–	0.02%	153
2018 Q3	$484K	Hold	4,485	–	–	0.02%	154
2018 Q2	$493K	Hold	4,485	–	–	0.02%	155
2018 Q1	$450K	Hold	4,485	–	–	0.02%	157
2017 Q4	$442K	Buy	4,485 +155	+4%	+$14.7K	0.02%	164
2017 Q3	$405K	Buy	4,330 +330	+8%	+$35K	0.02%	162
2017 Q2	$445K	Hold	4,000	–	–	0.02%	158
2017 Q1	$393K	Hold	4,000	–	–	0.02%	161
2016 Q4	$368K	Hold	4,000	–	–	0.02%	175
2016 Q3	$339K	Hold	4,000	–	–	0.02%	175
2016 Q2	$326K	Hold	4,000	–	–	0.02%	170
2016 Q1	$286K	Hold	4,000	–	–	0.01%	178
2015 Q4	$285K	Hold	4,000	–	–	0.01%	184
2015 Q3	$246K	Hold	4,000	–	–	0.01%	195
2015 Q2	$290K	Hold	4,000	–	–	0.01%	201
2015 Q1	$307K	Hold	4,000	–	–	0.01%	199
2014 Q4	$268K	Sell	4,000 -14	-0.3%	-$883	0.01%	206
2014 Q3	$244K	Buy	4,014 +14	+0.4%	+$863	0.01%	219
2014 Q2	$235K	Hold	4,000	–	–	0.01%	224
2014 Q1	$232K	Hold	4,000	–	–	0.01%	229
2013 Q4	$214K	Hold	4,000	–	–	0.01%	293
2013 Q3	$247K	Hold	4,000	–	–	0.01%	272
2013 Q2	$243K	Buy	+4,000	New	+$238K	0.01%	283

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Klingenstein Fields & Co's DGX Position: Q3 2025 in Review

Klingenstein Fields & Co sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 4,000 shares — an estimated $719K sold.

Klingenstein Fields & Co first reported a position in DGX in Q2 2013 and held it in 49 quarters. The position peaked at $719K in Q2 2025. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Klingenstein Fields & Co reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Klingenstein Fields & Co sold 4,000 Quest Diagnostics shares in Q3 2025, an estimated $719K.
Klingenstein Fields & Co first reported a position in Quest Diagnostics in Q2 2013 and held it in 49 quarters.
Klingenstein Fields & Co's Quest Diagnostics position peaked at $719K in Q2 2025.
1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Klingenstein Fields & Co's 13F filing for Q3 2025, filed 14 Nov 2025.